INR 79.0
(-2.71%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 151.81 Thousand INR | -97.66% |
2022 | 6.48 Million INR | 7040.47% |
2021 | -93.4 Thousand INR | 98.33% |
2020 | -5.59 Million INR | -295.48% |
2019 | 2.85 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 1.27 Million INR | 386.08% |
2023 Q3 | 217.56 Thousand INR | -6.28% |
2023 Q1 | 268.1 Thousand INR | -97.27% |
2023 Q4 | -445.99 Thousand INR | -304.99% |
2023 FY | 151.81 Thousand INR | -97.66% |
2023 Q2 | 232.13 Thousand INR | -13.41% |
2022 Q2 | 614.64 Thousand INR | 0.0% |
2022 FY | 6.48 Million INR | 7040.47% |
2022 Q3 | -8.53 Million INR | -1488.73% |
2022 Q4 | 9.81 Million INR | 214.94% |
2021 FY | -93.4 Thousand INR | 98.33% |
2020 FY | -5.59 Million INR | -295.48% |
2019 FY | 2.85 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alfavision Overseas (India) Limited | 2.76 Million INR | 94.507% |
Biocon Limited | 10.22 Billion INR | 99.999% |
Blue Jet Healthcare Limited | 1.63 Billion INR | 99.991% |
Concord Biotech Limited | 3.08 Billion INR | 99.995% |
Dishman Carbogen Amcis Limited | -1.53 Billion INR | 100.01% |
FERMENTA BIOTECH LIMITED | -230.59 Million INR | 100.066% |
Lyka Labs Limited | -24.89 Million INR | 100.61% |
Panacea Biotec Limited | -11.73 Million INR | 101.294% |
SAMSRITA LABS LIMITED | -2.62 Million INR | 105.789% |
Servoteach Industries Limited | -2.37 Million INR | 106.395% |
SMS Lifesciences India Limited | 90.92 Million INR | 99.833% |
Supriya Lifescience Limited | 1.19 Billion INR | 99.987% |
Syngene International Limited | 5.1 Billion INR | 99.997% |
TAKE Solutions Limited | -1.19 Billion INR | 100.013% |
Titan Biotech Limited | 248.53 Million INR | 99.939% |
Transgene Biotek Limited | -6.55 Million INR | 102.316% |
Vanta Bioscience Limited | -23.15 Million INR | 100.656% |